TRIB1 and cancer: Increased TRIB1 subsequently activates the PI3K/AKT pathway and promotes tumor cell proliferation, migration, and invasion, and treatment of resistance, eventually leading to the accumulation of cancer stem cells and the generation of multidrug resistance 44, 45.